SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.2%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$156M
AUM Growth
+$156M
(+7.2%)
Cap. Flow
-$4.09M
Cap. Flow
% of AUM
-2.63%
Top 10 Holdings %
Top 10 Hldgs %
70.68%
Holding
160
New
45
Increased
11
Reduced
31
Closed
38
Top Buys
| 1 |
Biogen
BIIB
|
$50.1M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$11.7M |
| 3 |
Cogent Biosciences
COGT
|
$9.38M |
| 4 |
Incyte
INCY
|
$6.82M |
| 5 |
Nektar Therapeutics
NKTR
|
$4.13M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$57.4M |
| 2 |
Esperion Therapeutics
ESPR
|
$8.92M |
| 3 |
SELLAS Life Sciences
SLS
|
$7.99M |
| 4 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$5.7M |
| 5 |
InspireMD
NSPR
|
$4.25M |
Sector Composition
| 1 | Healthcare | 86.15% |
| 2 | Consumer Staples | 2.32% |
| 3 | Consumer Discretionary | 0.64% |
| 4 | Materials | 0.5% |
| 5 | Technology | 0.45% |
